Rescula (unoprostone), a new eyedrop for glaucoma
June 2002
Novartis will soon introduce Rescula (unoprostone), a new eyedrop for glaucoma.
Rescula is a prostaglandin analogue...similar to Xalatan (latanoprost) and Travatan (travoprost).
These drugs lower intraocular pressure by increasing the outflow of aqueous humor. They're used second-line...for patients who can't tolerate or don't respond to other glaucoma meds.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive